A multicenter open-label phase II trial to evaluate nivolumab and ipilimumab for 2nd line therapy in elderly patients with advanced esophageal squamous cell cancer (RAMONA).

Nadja M Meindl-BeinkerJohannes BetgeTobias GuttingElke BurgermeisterSebastian BelleTianzuo ZhanNadine SchulteMartin MaenzMatthias P EbertNicolai Haertel

Published in: BMC cancer (2019)

EudraCT Number: 2017-002056-86 ; NCT03416244 , registered: 31.1.2018.

Keyphrases

squamous cell
open label
clinical trial
phase ii
phase iii
phase ii study
study protocol
middle aged
double blind
randomized controlled trial
squamous cell carcinoma
papillary thyroid
radiation therapy
placebo controlled
lymph node metastasis
replacement therapy
locally advanced